Skip to content

The Risk Factors Related to Rupture Flow-related Aneurysms in Posterior AVM

Risk Factors Related to Rupture Flow-related Aneurysms in Posterior Arteriovenious Malformation: A Muti-center Observentional Research.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07050381
Acronym
pAVM-rFA
Enrollment
200
Registered
2025-07-03
Start date
2025-06-13
Completion date
2026-12-31
Last updated
2025-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aneurysmatic Subarachnoid Haemorrhage, Aneurysm Cerebral, Aneurysm, Ruptured, Arteriovenous Malformation of Central Nervous System

Keywords

arteriovenous malformation, flow-related aneurysm, ruptured aneurysm, subarachnoid hemorrhage

Brief summary

AVMs have been reported to rupture at a formidable annual rate of 2% to 3% at natural progression, often resulting in longterm neurological deficits and poor functional outcomes.The reported risk of hemorrhagic presentation in patients with AVMs is 41% to 65%. While many studies suggest a correlation between higher hemorrhage risk and the concurrent presence of AVM and aneurysms, few authors have focused specifically on flow-related aneurysms alone. In many instances, the source of rupture is also unclear. Meta-analysis from 2016 suggested that 49.2% of hemorrhages were secondary to aneurysm rupture, 45% from AVM rupture, and 5.7% were undetermined.In a study of 302 patients, of which 52.6% had a hemorrhagic presentation, demonstrated a significant increase in rate of hemorrhage in those with flow-related aneurysms. Thus, it is necessary to figure out risk factors related to ruptured flow-related aneurysms in pAVM.

Interventions

None listed

Sponsors

The First Affiliated Hospital with Nanjing Medical University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. pAVM with flow-related aneurysms were identified by DSA, and subarachnoid hemorrhage was confirmed by CT 2. No history of stroke, Marfan syndrome, polycystic kidney disease

Exclusion criteria

1. pAVM without flow-related aneurysms 2. Absence of clinical data

Design outcomes

Primary

MeasureTime frameDescription
characteristics of flow-related aneurysmFrom enrollment to the end of treatment at 8 weekssize ratio(aneurysm depth (mm)/parent artery diameter (mm))

Other

MeasureTime frameDescription
demographic information of pAVM-rFAFrom enrollment to the end of treatment at 8 weeksgender
demographic informationFrom enrollment to the end of treatment at 8 weeksage when be hospitalized
characteristics of flow-related aneurysmFrom enrollment to the end of treatment at 8 weeksaspect ratio (aneurysm depth (mm)/aneurysm neck (mm))
characteristic of avmFrom enrollment to the end of treatment at 8 weeksavm location

Countries

China

Contacts

Primary ContactYifei Wang
wangyifei5323@163.com+86-13852665323

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026